semaglutide hf Effects of on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial Diabetes Drug Could Help Reduce

Continuous approval: You may need to demonstrate ongoing weight loss to maintain coverage

No human pharmacokinetic study has settled this

However, both berberine and semaglutide have been shown in clinical trials to help cells respond better to insulin

Fischman CM, Udey MC, Kurtz M, Wedner HJ

Glucagon Receptor Activation (Unique to Retatrutide) Increases energy expenditure Promotes fat oxidation instead of muscle breakdown Preserves lean mass by prioritizing fat as a fuel source This triple-action approach allows Retatrutide to outperform other medications like Ozempic, Wegovy, and Mounjaro in terms of fat loss while keeping muscle intact

Your call